BioCentury
ARTICLE | Clinical News

AS1411: Phase IIb discontinued

February 7, 2011 8:00 AM UTC

Antisoma discontinued an open-label, international Phase IIb trial of AS1411 after early data from about 45 patients showed that the compound was unlikely to show a clear benefit. The company said it ...